Labcorp beats quarterly profit estimates
Feb 16 (Reuters) - Laboratory Corp of America Holdings
LH.N on Thursday beat quarterly profit estimates, helped by
strength in its diagnostics business and demand for its drug
development services.
Excluding items, the company reported a profit of $4.14 per
share for the quarter ended Dec. 31, compared with analysts'
estimates of $4.10 per share, according to Refinitiv data.
(Reporting by Raghav Mahobe and Mariam E Sunny in Bengaluru;
Editing by Maju Samuel)
((Raghav.Mahobe@thomsonreuters.com;))
Recent news on Laboratory of America Holdings
See all newsBrief: Labcorp To Announce Second Quarter 2026 Financial Results On July 30, 2026
Brief: Labcorp And Epic Expand Collaboration To Advance Diagnostic Integration Across Hospitals And Health Systems
U.S. STOCKS ON THE MOVE-Quanta, O'Reilly Automotive, Avis
Labcorp lifts full‑year forecast as diagnostics business stays resilient (updated)
U.S. STOCKS ON THE MOVE-Qualcomm, Meta, Cardinal Health